AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
SURVEILLANCE FOR FACTOR-VIII INHIBITOR DEVELOPMENT IN THE CANADIAN HEMOPHILIA-A POPULATION FOLLOWING THE WIDESPREAD INTRODUCTION OF RECOMBINANT FACTOR-VIII REPLACEMENT THERAPY
Authors: GILES AR RIVARD GE TEITEL J WALKER I
Citation: Ar. Giles et al., SURVEILLANCE FOR FACTOR-VIII INHIBITOR DEVELOPMENT IN THE CANADIAN HEMOPHILIA-A POPULATION FOLLOWING THE WIDESPREAD INTRODUCTION OF RECOMBINANT FACTOR-VIII REPLACEMENT THERAPY, Transfusion science, 19(2), 1998, pp. 139-148
A DETAILED COMPARISON OF THE PERFORMANCE OF THE STANDARD VERSUS THE NIJMEGEN MODIFICATION OF THE BETHESDA ASSAY IN DETECTING FACTOR VIII-C INHIBITORS IN THE HEMOPHILIA-A POPULATION OF CANADA
Authors: GILES AR VERBRUGGEN B RIVARD GE TEITEL J WALKER I
Citation: Ar. Giles et al., A DETAILED COMPARISON OF THE PERFORMANCE OF THE STANDARD VERSUS THE NIJMEGEN MODIFICATION OF THE BETHESDA ASSAY IN DETECTING FACTOR VIII-C INHIBITORS IN THE HEMOPHILIA-A POPULATION OF CANADA, Thrombosis and haemostasis, 79(4), 1998, pp. 872-875
FACTOR-IX INHIBITORS AND ANAPHYLAXIS IN HEMOPHILIA-B
Authors: WARRIER I EWENSTEIN BM KOERPER MA SHAPIRO A KEY N DIMICHELE D MILLER RT PASI J RIVARD GE SOMMER SS KATZ J BERGMANN F LJUNG R PETRINI P LUSHER JM
Citation: I. Warrier et al., FACTOR-IX INHIBITORS AND ANAPHYLAXIS IN HEMOPHILIA-B, Journal of pediatric hematology/oncology, 19(1), 1997, pp. 23-27
FIBRINOGEN DEGRADATION PRODUCTS IN PATIENTS WITH THE QUEBEC PLATELET DISORDER
Authors: HAYWARD CPM WELCH B BOUCHARD M ZHENG S RIVARD GE
Citation: Cpm. Hayward et al., FIBRINOGEN DEGRADATION PRODUCTS IN PATIENTS WITH THE QUEBEC PLATELET DISORDER, British Journal of Haematology, 97(2), 1997, pp. 497-503
ALPHA-GRANULAR PROTEIN-DEGRADATION IN THE QUEBEC PLATELET DISORDER ISASSOCIATED WITH ABNORMAL SECRETABLE PLATELET SERINE-PROTEASE ACTIVITY
Authors: HAYWARD CPM ZHENG S BOUCHARD M RIVARD GE
Citation: Cpm. Hayward et al., ALPHA-GRANULAR PROTEIN-DEGRADATION IN THE QUEBEC PLATELET DISORDER ISASSOCIATED WITH ABNORMAL SECRETABLE PLATELET SERINE-PROTEASE ACTIVITY, Blood, 90(10), 1997, pp. 1149-1149
STUDIES OF A 2ND FAMILY WITH THE QUEBEC PLATELET DISORDER - EVIDENCE THAT THE DEGRADATION OF THE ALPHA-GRANULE MEMBRANE AND ITS SOLUBLE CONTENTS ARE NOT SECONDARY TO A DEFECT IN TARGETING PROTEINS TO ALPHA-GRANULES
Authors: HAYWARD CPM CRAMER EM KANE WH ZHENG SL BOUCHARD M MASSE JM RIVARD GE
Citation: Cpm. Hayward et al., STUDIES OF A 2ND FAMILY WITH THE QUEBEC PLATELET DISORDER - EVIDENCE THAT THE DEGRADATION OF THE ALPHA-GRANULE MEMBRANE AND ITS SOLUBLE CONTENTS ARE NOT SECONDARY TO A DEFECT IN TARGETING PROTEINS TO ALPHA-GRANULES, Blood, 89(4), 1997, pp. 1243-1253
FACTOR-IX INHIBITORS AND ANAPHYLAXIS IN HEMOPHILIA-B
Authors: WARRIER I EWENSTEIN BM KOERPER MA SHAPIRO A KEY N DIMICHELE D MILLER RT PASI J RIVARD GE SOMMER SS BERGMANN F LUSHER JM
Citation: I. Warrier et al., FACTOR-IX INHIBITORS AND ANAPHYLAXIS IN HEMOPHILIA-B, Haemophilia, 2(4), 1996, pp. 259-260
EVALUATION OF A SCREENING-TEST FOR THE QUEBEC QUALITATIVE PLATELET
Authors: HAYWARD CPM WELCH B BOUCHARD M ZHENG S RIVARD GE
Citation: Cpm. Hayward et al., EVALUATION OF A SCREENING-TEST FOR THE QUEBEC QUALITATIVE PLATELET, Blood, 88(10), 1996, pp. 1273-1273
THE DEGRADATION OF THE ALPHA-GRANULE MEMBRANE AND ITS SOLUBLE CONTENTS IN THE QUEBEC, QUALITATIVE PLATELET DISORDER IS NOT SECONDARY TO A DEFECT IN TARGETING PROTEINS TO ALPHA-GRANULES
Authors: HAYWARD CPM CRAMER EM KANE WH ZHENG S BOUCHARD M MASSE JM RIVARD GE
Citation: Cpm. Hayward et al., THE DEGRADATION OF THE ALPHA-GRANULE MEMBRANE AND ITS SOLUBLE CONTENTS IN THE QUEBEC, QUALITATIVE PLATELET DISORDER IS NOT SECONDARY TO A DEFECT IN TARGETING PROTEINS TO ALPHA-GRANULES, Blood, 88(10), 1996, pp. 1859-1859
FACTOR-V QUEBEC REVISITED
Authors: JANEWAY CM RIVARD GE TRACY PB MANN KG
Citation: Cm. Janeway et al., FACTOR-V QUEBEC REVISITED, Blood, 87(9), 1996, pp. 3571-3578
MEDIASTINAL BLEEDING AFTER CARDIOPULMONARY BYPASS IN PEDIATRIC-PATIENTS
Authors: GUAY J RIVARD GE
Citation: J. Guay et Ge. Rivard, MEDIASTINAL BLEEDING AFTER CARDIOPULMONARY BYPASS IN PEDIATRIC-PATIENTS, The Annals of thoracic surgery, 62(6), 1996, pp. 1955-1960
THE PREVALENCE OF FACTOR-VIII INHIBITORS DETECTED IN A NATIONAL STUDYTO ASSESS THE EFFECT OF WIDESPREAD INTRODUCTION OF HIGH-PURITY FACTOR-VIII FOR THE TREATMENT OF HEMOPHILIA-A
Authors: GILES AR RIVARD GE TEITEL J WALKER I LILLICRAP D DWYRE L
Citation: Ar. Giles et al., THE PREVALENCE OF FACTOR-VIII INHIBITORS DETECTED IN A NATIONAL STUDYTO ASSESS THE EFFECT OF WIDESPREAD INTRODUCTION OF HIGH-PURITY FACTOR-VIII FOR THE TREATMENT OF HEMOPHILIA-A, Thrombosis and haemostasis, 73(6), 1995, pp. 1029-1029
IDENTIFICATION OF AN AUTOSOMAL-DOMINANT BLEEDING DISORDER WITH A COMBINED DEFICIENCY OF PLATELET MULTIMERIN AND PLATELET FACTOR-V
Authors: HAYWARD CPM RIVARD GE MOORE JC KELTON JG
Citation: Cpm. Hayward et al., IDENTIFICATION OF AN AUTOSOMAL-DOMINANT BLEEDING DISORDER WITH A COMBINED DEFICIENCY OF PLATELET MULTIMERIN AND PLATELET FACTOR-V, Thrombosis and haemostasis, 73(6), 1995, pp. 1190-1190
REPLACEMENT THERAPY WITH A MONOCLONAL-ANTIBODY PURIFIED PROTEIN-C CONCENTRATE IN NEWBORNS WITH SEVERE CONGENITAL PROTEIN-C DEFICIENCY
Authors: DREYFUS M MASTERSON M DAVID M RIVARD GE MULLER FM KREUZ W BEEG T MINFORD A ALLGROVE J BERGMANN F MITCHELL VE HAWORTH C NELSON K SCHWARZ HP
Citation: M. Dreyfus et al., REPLACEMENT THERAPY WITH A MONOCLONAL-ANTIBODY PURIFIED PROTEIN-C CONCENTRATE IN NEWBORNS WITH SEVERE CONGENITAL PROTEIN-C DEFICIENCY, Seminars in thrombosis and hemostasis, 21(4), 1995, pp. 371-381
LOW-RISK OF VIRAL-INFECTION AFTER ADMINISTRATION OF VAPOR-HEATED FACTOR-VII CONCENTRATE OR FACTOR-IX COMPLEX IN FIRST-TIME RECIPIENTS OF BLOOD COMPONENTS
Authors: SHAPIRO A ABE T ALDEDORT LM ANDERLE K HILGARTNER MW KUNSCHAK M PRESTON FE RIVARD GE SCHIMPF K GLOWALLA MB KASPER CK GRIBBLE TJ HATHAWAY WE MANCOJOHNSON M SEARS DA TEBBI CK VOTAW M BLACHETTE VS SOULIERE D PETRINI P
Citation: A. Shapiro et al., LOW-RISK OF VIRAL-INFECTION AFTER ADMINISTRATION OF VAPOR-HEATED FACTOR-VII CONCENTRATE OR FACTOR-IX COMPLEX IN FIRST-TIME RECIPIENTS OF BLOOD COMPONENTS, Transfusion, 35(3), 1995, pp. 204-208
TREATMENT OF PURPURA FULMINANS IN MENINGOCOCCEMIA WITH PROTEIN-C CONCENTRATE
Authors: RIVARD GE DAVID M FARRELL C SCHWARZ HP
Citation: Ge. Rivard et al., TREATMENT OF PURPURA FULMINANS IN MENINGOCOCCEMIA WITH PROTEIN-C CONCENTRATE, The Journal of pediatrics, 126(4), 1995, pp. 646-652
UNTITLED - REPLY
Authors: RIVARD GE GIRARD M JUTRAS M MARTON D BELANGER R GUAY JP
Citation: Ge. Rivard et al., UNTITLED - REPLY, Journal of bone and joint surgery. American volume, 77A(5), 1995, pp. 807-808
A CHROMOGENIC ASSAY FOR ACTIVATED PROTEIN-C RESISTANCE
Authors: VARADI K MORITZ B LANG H BAUER K PRESTON E PEAKE I RIVARD GE KEIL B SCHWARZ HP
Citation: K. Varadi et al., A CHROMOGENIC ASSAY FOR ACTIVATED PROTEIN-C RESISTANCE, British Journal of Haematology, 90(4), 1995, pp. 884-891
MULTIMERIN DEFICIENCY IN A 2ND QUEBEC FAMILY
Authors: HAYWARD CPM RIVARD GE DROUIN J MOORE JC BOUCHARD M KELTON JG
Citation: Cpm. Hayward et al., MULTIMERIN DEFICIENCY IN A 2ND QUEBEC FAMILY, Blood, 86(10), 1995, pp. 2186-2186
CLINICAL-STUDY OF RECOVERY AND HALF-LIFE OF VAPOR-HEATED FACTOR-VII CONCENTRATE
Authors: RIVARD GE KOVAC I KUNSCHAK M THONE P COHEN LJ EYSTER ME GRIBBLE TJ HATHAWAY WE KASPER CK NEUBERG R RUSTAGI P SMITH K
Citation: Ge. Rivard et al., CLINICAL-STUDY OF RECOVERY AND HALF-LIFE OF VAPOR-HEATED FACTOR-VII CONCENTRATE, Transfusion, 34(11), 1994, pp. 975-979
ECONOMICS OF INHIBITOR TREATMENT IN CANADA
Authors: RIVARD GE VICK S
Citation: Ge. Rivard et S. Vick, ECONOMICS OF INHIBITOR TREATMENT IN CANADA, Seminars in hematology, 31(2), 1994, pp. 41-43
SYNOVIORTHESIS WITH COLLOIDAL P-32 CHROMIC PHOSPHATE FOR THE TREATMENT OF HEMOPHILIC ARTHROPATHY
Authors: RIVARD GE GIRARD M BELANGER R JUTRAS M GUAY JP MARTON D
Citation: Ge. Rivard et al., SYNOVIORTHESIS WITH COLLOIDAL P-32 CHROMIC PHOSPHATE FOR THE TREATMENT OF HEMOPHILIC ARTHROPATHY, Journal of bone and joint surgery. American volume, 76A(4), 1994, pp. 482-488
A CHROMOGENIC ASSAY FOR ACTIVATED PROTEIN-C (APC) RESISTANCE
Authors: SCHWARZ HP VARADI K MORITZ B LANG H BAUER K PRESTON E PEAKE I RIVARD GE
Citation: Hp. Schwarz et al., A CHROMOGENIC ASSAY FOR ACTIVATED PROTEIN-C (APC) RESISTANCE, Blood, 84(10), 1994, pp. 10000084-10000084
IDENTIFICATION OF AN AUTOSOMAL-DOMINANT BLEEDING DISORDER THAT IS ASSOCIATED WITH A DEFICIENCY OF PLATELET MULTIMERIN AND A DEFECT IN PLATELET FACTOR-V
Authors: HAYWARD CPM RIVARD GE MOORE JC KELTON JG
Citation: Cpm. Hayward et al., IDENTIFICATION OF AN AUTOSOMAL-DOMINANT BLEEDING DISORDER THAT IS ASSOCIATED WITH A DEFICIENCY OF PLATELET MULTIMERIN AND A DEFECT IN PLATELET FACTOR-V, Blood, 84(10), 1994, pp. 10000110-10000110
CIRCADIAN TIME-DEPENDENT RESPONSE OF CHILDHOOD LYMPHOBLASTIC-LEUKEMIATO CHEMOTHERAPY - A LONG-TERM FOLLOW-UP-STUDY OF SURVIVAL
Authors: RIVARD GE INFANTERIVARD C DRESSE MF LECLERC JM CHAMPAGNE J
Citation: Ge. Rivard et al., CIRCADIAN TIME-DEPENDENT RESPONSE OF CHILDHOOD LYMPHOBLASTIC-LEUKEMIATO CHEMOTHERAPY - A LONG-TERM FOLLOW-UP-STUDY OF SURVIVAL, Chronobiology international, 10(3), 1993, pp. 201-204
Risultati: 1-25 | 26-29